Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
about
A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma.Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis.TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cellsALK gene amplification is associated with poor prognosis in colorectal carcinomaDeath receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer.Cell surface markers in colorectal cancer prognosis.Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2.Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology.Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.
P2860
Q33945376-E491DB35-284C-42A9-A7A7-27975D3BF1C2Q34532108-84FE5621-17ED-4557-B9E5-C2403A479292Q34608366-CF1F6B52-76A7-41D4-B08C-93B702F63191Q35136665-6760944F-A020-41E4-B98E-9EFF7CCE7F59Q35832412-71C1C2FC-DEF8-4AF1-A368-F7FD033C3F36Q36883777-B03AF271-ADE0-4A48-B2E9-2E78A1E28285Q37323062-4205765F-F57B-4B90-B329-C9302F661EBDQ37402581-3E80DBDF-F6C6-4AF9-9822-28ACFD9427AFQ37845669-15A4C99C-6D3A-43F1-AAC6-2E178B420CE8Q38244150-D81A8086-089A-4080-A690-B2B1BCC7C1C6Q38557486-6EED8C13-553F-4480-8140-4E8E9CDEAA41Q44707208-311B16B2-79A1-40F9-8C5B-722973D3663BQ46952217-FCEBA496-DA8A-4298-B978-1D75964CB510Q53584232-3775FE90-E19E-4FB7-A7C8-A9CE6158FE23
P2860
Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@ast
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@en
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@nl
type
label
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@ast
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@en
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@nl
prefLabel
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@ast
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@en
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@nl
P2093
P2860
P356
P1433
P1476
Prognostic significance of TRA ...... to oncogenic KRAS alterations
@en
P2093
Alaa Abduljabbar
Azhar R Hussain
Fouad Al-Dayel
Jehad Abubaker
Khawla S Al-Kuraya
Luai H Ashari
Nasser Al-Sanea
Prashant Bavi
Samar Alhomoud
Sarita E Prabhakaran
P2860
P2888
P356
10.1186/1476-4598-9-203
P577
2010-07-30T00:00:00Z
P5875
P6179
1009180870